The French National Reference Centre of GTD
This is about a French national centre set up to help women with a rare condition called gestational trophoblastic disease (GTD), which includes things like molar pregnancies. Since 1999, the centre has been working to improve how GTD is managed in France. They register about 850 new cases each year and help treat around 140 women, often using chemotherapy or surgery. The centre works with your local doctor, offering advice, expert opinions, and keeping an eye on your progress. They ensure you get the right tests and treatment, and help coordinate care between local teams and national experts.
At a glance
What is this study about?
Imagine you've been diagnosed with a rare condition that sometimes happens during pregnancy, like a molar pregnancy, or another related issue called gestational trophoblastic disease (GTD). This French centre is designed to make sure you get the best possible care. They act like a central hub, gathering information on all cases across France, which helps them learn more about the condition and improve treatments for everyone.
When your local doctor finds out you have GTD, they can contact this centre. The centre then works with your doctor to give expert advice, help with your diagnosis, and guide your treatment. You'll still see your local doctor and go to your local lab for specific blood tests, but the centre's experts in places like Lyon will be behind the scenes, making sure everything is on track and helping your local team.
They keep a close eye on your progress, especially with blood tests. If anything looks unusual, or if your condition needs more advanced treatment like chemotherapy or surgery, the centre will work quickly with your doctor to plan the next steps. They aim to provide expert support, making sure you get specialist care no matter where you are in France.
Key takeaways
- Expert oversight for rare pregnancy-related conditions.
- Your local doctor remains your primary contact.
- Centralised monitoring of blood tests and diagnosis.
- Access to a national network of specialists.
- Personalised treatment plans based on expert guidance.
- Aims to improve care and understanding of GTD across France.
Who may be eligible?
This centre is open to women who have a confirmed diagnosis of gestational trophoblastic disease (GTD). This means that a doctor has looked at tissue samples under a microscope and found signs of the disease, or blood tests (hCG levels) show that GTD is present and not improving normally.
Essentially, if your doctor has officially diagnosed you with any form of gestational trophoblastic disease, or if your hCG levels are behaving in a way that suggests you have it, then you would be suitable for care and monitoring through this centre. There are no other reasons listed that would prevent you from being included.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Have I been diagnosed with a molar pregnancy or related condition?
- Have my hCG blood test results been unusual or concerning?
- Has a doctor told me I have 'gestational trophoblastic disease'?
- Am I willing for my doctor to share my medical information with the centre?
What does participation involve?
If you are involved with this centre, your local doctor will remain your main point of contact. The centre will provide expert advice and support to your doctor, but you'll generally continue to have your appointments and tests, like hCG blood monitoring, at your local clinic or hospital. The centre will ask your doctor to share your information, such as your diagnosis and blood test results, so they can keep track of your progress and offer guidance.
They also involve their expert pathologists to re-check your initial tissue diagnosis to ensure it's absolutely correct. If your condition changes or needs more intense treatment, the centre's specialists will work closely with your local doctor to decide the best plan, which might include specific scans or treatments like chemotherapy or surgery. They will communicate with your doctor at different stages, from when you first join to when your follow-up is complete. The overall duration of your involvement depends on your specific condition and how long your follow-up needs to be, sometimes lasting for months.
Potential risks and benefits
Locations (1)
- Centre des Maladies Trophoblastiques Centre Hospitalier Lyon Sud-Bâtiment 3B-2ème étage, 165 Chemin du Grand RevoyetVerified postcodePierre-Bénite, France· Recruiting
Common questions
What is Gestational Trophoblastic Disease (GTD)?
GTD is a group of rare conditions that can happen during or after pregnancy, like a molar pregnancy or more serious conditions that develop from pregnancy cells.
Will I have to travel to this centre in France?
No, generally you'll continue to see your local doctor. The centre provides expert advice and support to your local medical team remotely.
Who will be my main doctor?
Your local gynaecologist or oncologist will remain your main doctor and the person you talk to most about your care.
What is hCG monitoring?
hCG is a hormone produced during pregnancy. Monitoring its levels through blood tests helps doctors track GTD and see if treatment is working.
What if my condition needs specific treatment?
If you need specific treatment like chemotherapy or surgery, the centre's experts will work with your local doctor to plan the best course of action.
How to find out more
François Golfier, Pr
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.